Skip to content

Clinical trials

Terminated Glucose Metabolism Disorders trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glucose Metabolism Disorders Status: Terminated Country / region: United States Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20082
20092
20121
20181
20191
20201
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Meredith Hawkins2
Denver Health and Hospital Authority1
Diva De Leon1
Lakewood-Amedex Inc1
Orexigen Therapeutics, Inc1
Sansum Diabetes Research Institute1
Takeda1
University Hospitals Cleveland Medical Center1
University of North Carolina, Chapel Hill1
VIVUS LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glucose Metabolism Disorders11
Diabetes Mellitus8
Diabetes Mellitus, Type 27
Metabolic Diseases5
Cardiovascular Diseases4
Endocrine System Diseases4
Heart Diseases2
Vascular Diseases2
Body Weight1
Congenital Hyperinsulinism1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.